These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 23163650)

  • 1. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
    Makinodan E; Marneros AG
    Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
    Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
    J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures.
    Cohen JR; Resnick DZ; Niewiadomski P; Dong H; Liau LM; Waschek JA
    BMC Cancer; 2010 Dec; 10():676. PubMed ID: 21143927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between sonic hedgehog pathway gene polymorphisms and basal cell carcinoma development in the Polish population.
    Lesiak A; Sobolewska-Sztychny D; Majak P; Sobjanek M; Wodz K; Sygut KP; Majsterek I; Wozniacka A; Narbutt J
    Arch Dermatol Res; 2016 Jan; 308(1):39-47. PubMed ID: 26590974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonic hedgehog pathway dysregulation in skin basal-cell carcinoma of a Polish population.
    Lesiak A; Sobolewska-Sztychny D; Danilewicz M; Rogowski-Tylman M; Sysa-Jedrzejowska A; Sobjanek M; Olejniczak-Staruch I; Narbutt J
    Folia Histochem Cytobiol; 2013; 51(3):219-24. PubMed ID: 24203628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
    Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
    Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas.
    Atwood SX; Li M; Lee A; Tang JY; Oro AE
    Nature; 2013 Feb; 494(7438):484-8. PubMed ID: 23446420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis.
    Hu MC; Mo R; Bhella S; Wilson CW; Chuang PT; Hui CC; Rosenblum ND
    Development; 2006 Feb; 133(3):569-78. PubMed ID: 16396903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of PACAP with Sonic hedgehog reveals complex regulation of the hedgehog pathway by PKA.
    Niewiadomski P; Zhujiang A; Youssef M; Waschek JA
    Cell Signal; 2013 Nov; 25(11):2222-30. PubMed ID: 23872071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
    Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
    Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line.
    Werminghaus P; Haase M; Hornsby PJ; Schinner S; Schott M; Malendowicz LK; Lammers BJ; Goretzki PE; Müller-Mattheis V; Markus Giessing ; Willenberg HS
    J Steroid Biochem Mol Biol; 2014 Jan; 139():7-15. PubMed ID: 24063979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signalling in skin development and cancer.
    Athar M; Tang X; Lee JL; Kopelovich L; Kim AL
    Exp Dermatol; 2006 Sep; 15(9):667-77. PubMed ID: 16881963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
    Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG
    PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule modulators of the Sonic Hedgehog signaling pathway.
    Stanton BZ; Peng LF
    Mol Biosyst; 2010 Jan; 6(1):44-54. PubMed ID: 20024066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
    Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
    Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
    Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
    Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of sonic hedgehog signal transducers, patched and smoothened, in human basal cell carcinoma.
    Tojo M; Mori T; Kiyosawa H; Honma Y; Tanno Y; Kanazawa KY; Yokoya S; Kaneko F; Wanaka A
    Pathol Int; 1999 Aug; 49(8):687-94. PubMed ID: 10504535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The magnitude of hedgehog signaling activity defines skin tumor phenotype.
    Grachtchouk V; Grachtchouk M; Lowe L; Johnson T; Wei L; Wang A; de Sauvage F; Dlugosz AA
    EMBO J; 2003 Jun; 22(11):2741-51. PubMed ID: 12773389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating Smoothened mutations in sporadic basal-cell carcinoma.
    Xie J; Murone M; Luoh SM; Ryan A; Gu Q; Zhang C; Bonifas JM; Lam CW; Hynes M; Goddard A; Rosenthal A; Epstein EH; de Sauvage FJ
    Nature; 1998 Jan; 391(6662):90-2. PubMed ID: 9422511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.